Ketotifen fumarateProduct ingredient for Ketotifen
- Name
- Ketotifen fumarate
- Drug Entry
- Ketotifen
Ketotifen is a benzocycloheptathiophene derivative3 with potent antihistaminic and mast cell stabilizing properties. It has a similar structure to some other first-generation antihistamines such as cyproheptadine and azatadine.3
Ketotifen was first developed in Switzerland in 1970 by Sandoz Pharmaceuticals and was initially marketed for the treatment of anaphylaxis.3 In the US, it is now used in an over-the-counter ophthalmic formulation for the treatment of itchy eyes associated with allergies,6 and in Canada a prescription-only oral formulation is available and indicated as an add-on therapy for children with atopic asthma.7 In addition, oral ketotifen is used in Mexico and across Europe for the treatment of various allergic symptoms and disorders,3 including urticaria, mastocytosis, and food allergy.
- Accession Number
- DBSALT001856
- Structure
- Synonyms
- 10H-BENZO(4,5)CYCLOHEPTA(1,2-B)THIOPHEN-10-ONE, 4,9-DIHYDRO-4-(1-METHYL-4-PIPERIDINYLIDENE)-, (E)-2-BUTENEDIOATE (1:1) / 4,9-Dihydro-4-(1-methyl-4-piperidylidene)-10H-benzo[4,5]cyclohepta[1,2-b]thiophen-10-one fumarate (1:1) / HC 20,511 FUMARATE / HC-20511 FUMARATE / Ketotifen (as fumarate) / Ketotifen hydrogen fumarate
- External IDs
- NSC-757415